Ajax-Loading

Sino Biopharmaceutical Ltd - Debt To Assets Ratio

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.

The item "Debt-To-Assets-Ratio" stands at 15.85 percent as of 06/30/2025, the highest value since 03/31/2024.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Debt To Assets Ratio" stands at 15.85 Percent. This represents an increase of 4.00 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.58 percentage points compared to the value the year prior.
The 1 year change in percentage points is 1.58.
The 3 year change in percentage points is -2.24.

The Serie's long term average value is 15.54 percent. It's latest available value, on 06/30/2025, is 0.308 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is +9.51.
The Serie's change in percentage points from it's maximum value, on 12/31/2022, to it's latest available value, on 06/30/2025, is -5.68.

Debt To Assets Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Assets Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Assets Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Assets Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Assets Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Assets Ratio280,205,508,085.11